CTLA4 and neoplasm: Next, to investigate whether the different response between CT-26 and Colon 26 was specific for anti-PD-1 or common for ICB, we tested anti-PD-1 and anti-CTLA-4 mAb in both CT-26 and Colon 26 tumor-bearing mice.